¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
¼¼°èÀÇ ÀÇ·á¿ë ·Îº¿ ¹× ÄÄÇ»ÅÍ Áö¿ø ¼ö¼ú ½ÃÀå ±Ô¸ð´Â 2023³â 115¾ï ´Þ·¯¿¡¼ ¿¹Ãø ±â°£ Áß 11.0%ÀÇ CAGR·Î ÃßÀÌÇϸç, 2028³â¸»¿¡´Â 195¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼ö¼ú¿ë ·Îº¿ ½Ã½ºÅÛ ºÎ¹®Àº 2023³â 83¾ï ´Þ·¯¿¡¼ °°Àº ±â°£ Áß 11.2%ÀÇ CAGR·Î ÃßÀÌÇϸç, 2028³â¸»¿¡´Â 142¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ÀçȰ¿ë ·Îº¿ ½Ã½ºÅÛ ºÎ¹®Àº 2023³â 32¾ï ´Þ·¯¿¡¼ CAGR 10.5%·Î ÃßÀÌÇϸç, 2028³â¸»¿¡´Â 53¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ÀÇ·á¿ë ·Îº¿ ¹× ÄÄÇ»ÅÍ Áö¿ø ¼ö¼ú ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ¹ý±ÔÁ¦ ȯ°æ, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸÀÇ ºÐ¼®, ½ÃÀå ±Ô¸ðÀÇ ÃßÀÌ¡¤¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀåÀÇ Àü¸Á
- Á¶»ç ¹üÀ§
- ½ÃÀå ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
- °³¿ä
- ÀÇ·á¿ë ·Îº¿ÀÇ À¯Çü¿¡ °üÇÑ ÀλçÀÌÆ®
- °ø±Þ¸Á°ú ¹°·ù
Á¦3Àå ½ÃÀå ¿ªÇÐ
- ½ÃÀå ÃËÁø¿äÀÎ
- Àúħ½À¼ö¼úÀÇ ¼ö¿ä Áõ°¡
- ·Îº¿ ¼ö¼úÀÇ ¾ÈÀü¼º, ½Å·Ú¼º, È¿À²¼º
- ÀçȰ ·Îº¿ÀÇ ¼ö¿ä Áõ°¡
- ½ÃÀå ¾ïÁ¦¿äÀÎ
- ÀÇ·á ·Îº¿¿¡ °üÇÑ ±ÔÁ¦ ±âÁØÀÇ °á¿©
- ¾×¼¼½º¿Í °¡°Ý»ó Á¦¾à
- ½ÃÀå ±âȸ
- ÀÇ·á ¹× ¼ö¼ú¿ë ·Îº¿¿¡¼ ÷´Ü ±â¼úÀÇ ÀÌ¿ë Áõ°¡
- Àå±â°è Àüü¿¡ °ÉÄ£ ¼ö¼ú ´É·Â°ú ÀÀ¿ëÀÇ Çâ»ó
- ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
- °¡ÆÄ¸¥ ÇнÀ °î¼±°ú ¿Ü°úÀǸ¦ À§ÇÑ ±³À° ºÎÁ·
- °¡°Ý°ú ¿¹»ê»ó Á¦¾à
Á¦4Àå ½Å±Ô ±â¼ú ¹× °³¹ß
- ½Å±Ô ±â¼ú
- ¼ÒÇüÈ¿Í ¸¶ÀÌÅ©·Î ·Îº¿
- AI¿Í ±â°èÇнÀ
- ¿Ü°ú¼ö¼ú¿¡¼ ÅÚ·¹ÇÁ·¹Àü½º¿Í ¼¼°èÀÇ ¹ø¿ª
- ƯÇ㠺м®
- ÀÓ»ó½ÃÇè
- ÀÓ»ó½ÃÇè : ¼ºº°
- ÀÓ»ó½ÃÇè : ¿¬±¸ À¯Çüº°
- ÀÓ»ó½ÃÇè : ¿ëµµº°
Á¦5Àå ½ÃÀå ºÎ¹® ºÐ¼®
- ºÎ¹®º° ³»¿ª
- ½ÃÀå ³»¿ª : Á¦Ç° À¯Çüº°
- ½ÃÀå ³»¿ª : ¿ëµµº°
- ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°
- Áö¿ªÀû ³»¿ª
- ½ÃÀå ³»¿ª : Áö¿ªº°
- ½ÃÀå ºÐ¼®¡¤¿¹Ãø
- ºÏ¹Ì
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ±âŸ Áö¿ª
Á¦6Àå °æÀï Á¤º¸
- ±â¾÷ÀÇ ½ÃÀå Á¡À¯À²
- Á¦Ç°
- Àü·« ºÐ¼®
- M&A¿Í º¥Ã³ ÆÝµù
- ±ÔÁ¦ »óȲ
Á¦7Àå ÀÇ·á ·Îº¿ »ê¾÷¿¡¼ÀÇ Áö¼Ó°¡´É¼º : ESG °üÁ¡
- Àúħ½À¼ö¼ú(MIS)°ú Áö¼Ó°¡´É¼º
- ESG »ç·Ê ¿¬±¸
- Á÷°¨ÀûÀÎ ¿Ü°ú¼ö¼ú
- BCC¿¡ ÀÇÇÑ °á·Ð
Á¦8Àå ºÎ·Ï
- Á¶»ç ¹æ¹ý
- Àü½Ã/Âü°í ¹®Çå
- Á¤ÀÇ/¾à¾î
- Á¤ÀÇ
- ¾à¾î
- ±â¾÷ °³¿ä
- CYBERDYNE INC.
- EKSO BIONICS
- INTUITIVE SURGICAL OPERATIONS INC.
- LIFEWARD INC.
- MEDTRONIC
- STRYKER
- ZIMMER BIOMET
KSA 24.05.14
The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
The global market for surgical robotic systems is expected to grow from $8.3 billion in 2023 and projected to reach $14.2 billion by the end of 2028, at a CAGR of 11.2% during the forecast period of 2023 to 2028.
The global market for rehabilitative robotic systems is expected to grow from $3.2 billion in 2023 and projected to reach $5.3 billion by the end of 2028, at a CAGR of 10.5% during the forecast period of 2023 to 2028.
Report Scope
This goal of this report is to study the global market for medical robotics and computer-assisted surgery, and determine its size by estimating current revenues by product, indication, end user and region.
Report Includes
- 38 data tables and 33 additional tables
- An overview of the global market for medical robotics and computer-assisted surgery (MRCAS)
- Analysis of global market trends, featuring historical revenue data for 2020-2023, forecasts for 2028, and projections of compound annual growth rates (CAGRs) through 2028
- Evaluation of the current market's size and revenue growth prospects specific to MRCAS, along with a market share analysis by product, application, end user and geographic region
- A look at emerging technology trends, gaps and opportunities in the market estimating current and future demand for MRCAS, and identification of the companies best positioned to meet this demand
- Facts and figures pertaining to market drivers and restraints, as well as ESG trends
- Identification of promising new surgical procedures and products still in the development and testing stages, and their probability of successful commercial launch within the next five years
- Impact of COVID-19 on the MRCAS market.
- Insight into the growth development strategies of major MRCAS manufacturers
- Information on latest industry developments, including R&D, emerging technologies and economic trends
- Market share analysis for the key companies of the industry and coverage of their proprietary technologies, patents, and strategic alliances and other market strategies
- Profiles of the leading companies in the industry, including Intuitive Surgical Operations Inc., Medtronic, Stryker, and Zimmer Biomet
Table of Contents
Chapter 1 Introduction
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Insight into Types of Medical Robots
- Supply Chain and Logistics
Chapter 3 Market Dynamics
- Introduction
- Market Drivers
- Rising Demand for Minimally Invasive Procedures
- Safety, Reliability and Efficiency for Robotic Surgery
- Increased Demand for Rehabilitation Robots
- Market Restraints
- Lack of Regulatory Norms for Medical Robotics
- Limited Access and Affordability
- Market Opportunities
- Increased Use of Advanced Technologies in Medical and Surgical Robotics
- Increase in Procedural Capabilities and Application across Organ Systems
- Market Challenges
- Steep Learning Curve and Lack of Training for Surgeons
- Affordability and Budget Constraints
Chapter 4 Emerging Technologies and Developments
- Emerging Technologies
- Miniaturization and Micro-robotics
- AI and Machine Learning
- Telepresence in Surgery and Global Translation
- Patent Analysis
- Clinical Trials
- Clinical Trials by Gender
- Clinical Trials by Study Type
- Clinical Trials by Application
Chapter 5 Market Segment Analysis
- Breakdown by Segment
- Market Breakdown by Type of Product
- Market Breakdown by Application
- Market Breakdown by End User
- Geographic Breakdown
- Global Market Breakdown by Region
- Market Analysis and Forecast
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Company Market Shares
- Products
- Strategic Analysis
- M&A and Venture Funding
- Regulatory Landscape
- Introduction
- U.S. Regulations
- Regulations in China
- EU Regulations
Chapter 7 Sustainability in the Medical Robotics Industry: An ESG Perspective
- Minimally Invasive Surgery (MIS) and Sustainability
- ESG Case Study
- Intuitive Surgical
- Concluding Remarks from BCC
Chapter 8 Appendix
- Methodology
- Sources/References
- Definitions/Abbreviations
- Definitions
- Abbreviations
- Company Profiles
- CYBERDYNE INC.
- EKSO BIONICS
- INTUITIVE SURGICAL OPERATIONS INC.
- LIFEWARD INC.
- MEDTRONIC
- STRYKER
- ZIMMER BIOMET